95%Confidence
0Views
FDASource
2026-03-03Date
Summary
Amerisource Health Services faces a Class II recall for oxycodone blister pack defects, creating diversion risks for controlled substances. This could trigger DEA scrutiny and supply chain disruptions for pain management medications.
Actionable: Implement enhanced inspection of all Amerisource oxycodone shipments and report defective units to DEA immediately.
AI Confidence: 95%
Data Points
firmAmerisource Health Services LLC
classificationClass II
statusOngoing
distributionNationwide in the USA
productOxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now